Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.057 AUD | +5.56% |
|
-3.39% | -48.18% |
06-24 | Imugene Doses First Patient of Bile Tract Cancer in Phase One Clinical Trial; Shares Decline 6% | MT |
04-16 | Imugene Signs Deal to Sell Manufacturing Facility For $6 Million | MT |
- Stock Market
- Equities
- IMU Stock
- News Imugene Limited
- MarketScreener Editorial Features